
SOLV
Healthcare · Medical Instruments & Supplies · $15.14B market cap
$89.08+0.27 (+0.3%)Nov 13, 4:16 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +0.1% over 90 days · 30-day revisions 4 up, 4 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | 1.35 | 1.45 | +7.4% |
| Aug 5, 2026 | After the close | 1.91 | 2.55 | +33.5% |
| May 5, 2026 | After the close | 1.35 | 1.48 | +9.6% |
| Feb 26, 2026 | Time not confirmed | 1.50 | 1.57 | +4.7% |
| Nov 6, 2025 | After the close | 1.43 | 1.50 | +4.9% |
| Aug 7, 2025 | After the close | 1.45 | 1.69 | +16.6% |
| May 8, 2025 | After the close | 1.22 | 1.34 | +9.8% |
| Feb 27, 2025 | Time not confirmed | 1.50 | 1.41 | -6.0% |
| Nov 7, 2024 | After the close | 1.39 | 1.64 | +18.0% |
| Aug 8, 2024 | After the close | 1.51 | 1.56 | +3.3% |
| May 9, 2024 | Before the open | 1.75 | 2.08 | +18.9% |
| Feb 28, 2024 | Time not confirmed | — | 2.31 | — |
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin…